George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director George Medicines Appoints Mark Mallon as Chief Executive Officer and Board Director London, UK 29 April 2024 – George Medicines, a late-stage, biopharmaceutical company addressing significant unmet...

Cardiometabolic Disease Market Size Worth USD 868.45 Billion by 2032 at 24% CAGR – Report by Market Research Future (MRFR) New York, USA, May 10, 2023 (GLOBE NEWSWIRE) -- Cardiometabolic Disease Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), Cardiometabolic Disease Market...

Cardiometabolic Health Congress Announces Spring Conference Focused on Inflammation and Cardiometabolic Disease Boca Raton, FL, March 16, 2023 (GLOBE NEWSWIRE) -- In line with its mission to deliver quality medical education to combat the spectrum of cardiometabolic diseases, CMHC joins forces with the...